Mountain View Pharmaceuticals, Inc.

The path to achieving the promise of precision medicine – prevention and treatment strategies that take individual variability in genes, environment and lifestyle into account – must go through the di

With US FDA approval for Saxenda (liraglutide) Novo Nordisk could be a contender in the market for prescription weight loss drugs, which so far has yielded disappointing sales from oral obesity therap

23andMe, a genetic testing firm which entered a partnership in September with Pfizer to push the idea of personalized medicines (scripintelligence.com, 1 September 2014), has launched its Personal Gen

23andMe's announcement earlier this month that it had teamed up with Pfizer in inflammatory bowel disease (IBD) could pave the way for the expansion of personalized medicine into a new area. So far, t